About 300 reports

  • GLAXOSMITHKLINE ACQUIRED OKAIROS AG

AbbVie operates through only one division - Pharmaceutical Product.

  • Vaccine
  • United States
  • World
  • AbbVie Inc.
  • Amgen Inc.

The Companion Animal revenue growth was driven by its dermatology portfolio, in addition to new products, particularly Simparica (sarolaner) Chewables to kill adult fleas in dogs.

  • Vaccine
  • Veterinary Drug
  • World
  • Market Size
  • Boehringer Ingelheim GmbH
  • Biologics Market Key Mergers And Acquisitions

I THINK THE FIRST ONE WILL BE THE MOST DEMANDED ONE.

  • Vaccine
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 6. COMPETITIVE LANDSCAPE

TABLE OF CONTENTS ##.

  • Vaccine
  • AstraZeneca PLC
  • CSL Limited
  • GlaxoSmithKline plc
  • Indian Immunologicals Ltd
  • Biologics Market Key Mergers And Acquisitions

I THINK THE FIRST ONE WILL BE THE MOST DEMANDED ONE.

  • Vaccine
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • Sanofi S.A.

Novartis Oncology offers various drugs to treat rare diseases and cancers and also focuses on neuroscience, cardio-metabolic, ophthalmology, immunology, dermatology and respiratory.

  • Vaccine
  • Netherlands
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG

Novartis Oncology offers various drugs to treat rare diseases and cancers and also focuses on neuroscience, cardio-metabolic, ophthalmology, immunology, dermatology and respiratory.

  • Vaccine
  • United Kingdom
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • GLAXOSMITHKLINE

Top ## players hold majority of stake in the market ##.

  • Cardiovascular Disease
  • Diabetes
  • Endocrine Disease
  • Pathology
  • Vaccine

Beside, there are ## national bacteria strain preservation centers, ## bio safety laboratory, ## QA department and ## QC department in the Institute.

  • Vaccine
  • China
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Ltd. Qingdao Hopebio-Technology Co., Ltd.
  • Shenzhen Kangtai Biological Products Co.
  • Market challenges

Dermatologic lesions include exudative and necrotic dermatitis, urticaria, edema, and vesicles on the teats.

  • Vaccine
  • Forecast
  • Market Size
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.

Traditionally, a blockbuster drug is defined as one with annual sales of more than USD ## billion.

  • Vaccine
  • North America
  • United States
  • Market Size
  • F. Hoffmann-La Roche Ltd.

The auto exports exceeded over ## million each year.

  • Diagnostics
  • Interferon
  • Vaccine
  • China
  • Demand

It focuses on dermatological pathologies such as acne, mycosis, psoriasis, atopical dermatitis and alopecia.

  • Vaccine
  • AstraZeneca PLC
  • Laboratoires Pierre Fabre SA
  • Les Laboratoires Servier SAS
  • Sanofi S.A.

Beside, there are ## national bacteria strain preservation centers, ## bio safety laboratory, ## QA department and ## QC department in the Institute.

  • Vaccine
  • China
  • Novartis AG
  • Pfizer Inc.
  • Sanofi-Synthelabo Inc.
  • China's Market Entry
  • China's Market Entry

Beside, there are ## national bacteria strain preservation centers, ## bio safety laboratory, ## QA department and ## QC department in the Institute.

  • Vaccine
  • China
  • Market Size
  • Supply
  • Shenzhen Kangtai Biological Products Co.

Beside, there are ## national bacteria strain preservation centers, ## bio safety laboratory, ## QA department and ## QC department in the Institute.

  • Vaccine
  • China
  • Demand
  • Supply
  • Zhejiang Expressway Co., Ltd.

Ltd. and Shanghai No. ## Pharmaceutical Co.

  • Vaccine
  • China
  • Demand
  • Market Size
  • Dongguan Winnerway Bio-Tech Co., Ltd.

According to Virbac' s 2016 annual report: In the United States, historical ranges, notably dental and dermatological products, continued to see growth.

  • Vaccine
  • United States
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merck & Co., Inc.

Its performance was driven by continued growth in all three major market categories, including rheumatology, dermatology, and gastroenterology.

  • Cancer
  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • Vaccine
  • Combination products
  • Cough, cold and allergy remedies by type

From 2011 to 2016, regional retail value sales grew by ##% annually.

  • Vaccine
  • World
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi S.A.
  • Pipeline Landscape Assessment

British Journal of Dermatology; ##(##): ##-##.

  • Cancer
  • Cancer Immunotherapy
  • Cell Therapy
  • Therapy
  • Vaccine
  • Corporate Analysis
  • SWOT Analysis

The business includes the specialty areas of dermatology, respiratory and ophthalmics.

  • Vaccine
  • Allergan plc
  • Merck & Co., Inc.
  • Mylan Inc.
  • Pfizer Inc.
  • 5.4 NOVARTIS

Other Companies ##.

  • Vaccine
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.
  • 5.4 NOVARTIS

Tdap ##.

  • Vaccine
  • Demand
  • Market Size
  • bioCSL Inc.
  • GlaxoSmithKline plc
  • GLAXOSMITHKLINE PLC

It has three R& D centers (two in Germany and one in Spain).

  • Vaccine
  • Germany
  • Almirall, S.A.
  • Bayer AG
  • GlaxoSmithKline plc

Its performance was driven by continued growth in all three major market categories, including rheumatology, dermatology, and gastroenterology.

  • Cancer
  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • Vaccine
  • GLAXOSMITHKLINE PLC

In dermatology therapy area, the company, through its subsidiary Stiefel, offers prescription and over-the-counter skin care products.

  • Vaccine
  • Turkey
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG
  • Company: Injex Pharma AG
  • INJEX PHARMA AG

The newly formed Chinese-German company will focus on medical therapies to treat diabetes, vaccinations, local anesthetics and dermatological treatments.

  • Vaccine
  • Bioject Medical Technologies Inc.
  • Crossject
  • Inovio Pharmaceuticals, Inc.
  • MedImmune, LLC
  • GLAXOSMITHKLINE: YOY GROWTH AND REVENUE GENERATED FROM SALES OF PHARMACEUTICAL PRODUCTS 2011-2014 ($ BILLIONS)
  • GLAXOSMITHKLINE

This enabled the former to become the number-one generic dermatology medicines company.

  • Vaccine
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • GLAXOSMITHKLINE: BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014 ($ BILLIONS)
  • GLAXOSMITHKLINE

Genotype ## is the most common HCV.

  • Vaccine
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.